Jefferson E. Davis
Chief Business Officer, Opexa Therapeutics.
Companies
- Opexa TherapeuticsChief Business Officer Feb 5, 2021 to Nov 20, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Opexa Therapeutics0 shares2Nov 17, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 17, 2023Returned to company 71,645 shares of Opexa Therapeutics2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2